Literature DB >> 15751067

Chronic sarcoid arthritis treated with intraarticular etanercept.

Kathryn Hobbs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15751067     DOI: 10.1002/art.20936

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 2.  Cytokine modulators in the treatment of sarcoidosis.

Authors:  E Bargagli; C Olivieri; P Rottoli
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

Review 3.  Musculoskeletal Manifestations of Sarcoidosis.

Authors:  Georges El Hasbani; Imad Uthman; Ali Sm Jawad
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2022-02-14

Review 4.  Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments.

Authors:  Geir Smedslund; Annie Martina Kotar; Till Uhlig
Journal:  Rheumatol Int       Date:  2022-08-09       Impact factor: 3.580

5.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.